Phenyl lactic acid alleviates Samonella Typhimurium-induced colitis via regulating microbiota composition, SCFA production and inflammatory responses

2021 ◽  
Author(s):  
Qingqing Zhou ◽  
Rongcheng Gu ◽  
Bingyao Xue ◽  
Ping Li ◽  
Qing Gu
Keyword(s):  
Lactic Acid ◽  
Liver Enzyme ◽  
Inflammatory Responses ◽  
Microbiota Composition ◽  
Spleen Enlargement

PLA alleviates S. Typhimurium-induced colitis via decreasing the spleen enlargement and liver enzyme (AST and ALT) activities, and regulating microbiota, SCFA metabolism and inflammatory levels.

scholarly journals Multifunctional Biodegradable Vascular PLLA Scaffold with Improved X-ray Opacity, Anti-Inflammation, and Re-Endothelization

Polymers ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 1979
Author(s):  
Ho In Lee ◽  
Yun Heo ◽  
Seung-Woon Baek ◽  
Da-Seul Kim ◽  
Duck Hyun Song ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Inflammatory Responses ◽  
Neointimal Hyperplasia ◽  
Film Surface ◽  
High Mechanical Property ◽  
X Ray ◽  
Stent Restenosis ◽  
X Ray Computed ◽  
Hydrolysis Of

Poly(L-lactic acid) (PLLA) has been used as a biodegradable vascular scaffold (BVS) material due to high mechanical property, biodegradability, and biocompatibility. However, acidic byproducts from hydrolysis of PLLA reduce the pH after the surrounding implanted area and cause inflammatory responses. As a result, severe inflammation, thrombosis, and in-stent restenosis can occur after implantation by using BVS. Additionally, polymers such as PLLA could not find on X-ray computed tomography (CT) because of low radiopacity. To this end, here, we fabricated PLLA films as the surface of BVS and divided PLLA films into two coating layers. At the first layer, PLLA film was coated by 2,3,5-triiodobenzoic acid (TIBA) and magnesium hydroxide (MH) with poly(D,L-lactic acid) (PDLLA) for radiopaque and neutralization of acidic environment, respectively. The second layer of coated PLLA films is composed of polydopamine (PDA) and then cystamine (Cys) for the generation of nitric oxide (NO) release, which is needed for suppression of smooth muscle cells (SMCs) and proliferation of endothelial cells (ECs). The characterization of the film surface was conducted via various analyses. Through the surface modification of PLLA films, they have multifunctional abilities to overcome problems of BVS effectively such as X-ray penetrability, inflammation, thrombosis, and neointimal hyperplasia. These results suggest that the modification of biodegradable PLLA using TIBA, MH, PDA, and Cys will have important potential in implant applications.

Starch sources and concentration in diet of dairy goats affected ruminal pH and fermentation, and inflammatory response

2019 ◽  
Vol 59 (9) ◽  
pp. 1640
Author(s):  
Yizhao Shen ◽  
Fangfang Zhao ◽  
Lihuai Yu ◽  
Wenzhu Yang ◽  
Mengzhi Wang ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Milk Production ◽  
Milk Yield ◽  
Inflammatory Responses ◽  
Pearson Correlation ◽  
Dairy Goats ◽  
Blood Concentrations ◽  
Ruminal Ph ◽  
Amyloid A ◽  
Increased Risk

Corn and wheat grains are two starch sources with considerably different ruminal digestion rates, which may lead to differing lipopolysaccharide (LPS) release in both rumen and hindgut affecting animal production. The objectives of this study were to (1) investigate the effects of different ruminal and faecal LPS concentrations induced by starch source (corn vs wheat) and starch concentrations (low vs high) on DMI, ruminal pH, ruminal fermentation patterns, milk production, and inflammatory responses; and (2) evaluate the possible translocation site of LPS in dairy goats. Eight lactating dairy goats with ruminal cannulas were used in a replicated 4 × 4 Latin square design with 2 × 2 factorial arrangement of treatments. Each experimental period consisted of 24 days long including 21 days for adaption and 3 days for data and sample collection. The four treatment diets were: corn and wheat grain combined with low (LS) and high grain starch (HS). Goats were fed equal amounts of a total mixed ration twice daily at 0700 hours and 1900 hours. Replacing corn with wheat in goat diet led to longer (P < 0.02) duration of ruminal pH <5.6, higher ruminal LPS (P < 0.05), but lower faecal LPS concentration. However, no differences between two grains in ruminal pH (mean, minimum and maximum), volatile fatty acids (VFA) and lactic acid concentration were observed. Goats fed HS diets had lower (P < 0.01) ruminal pH and higher (P < 0.01) ruminal concentrations of VFA and lactic acid, as well as higher (P < 0.01) ruminal and faecal LPS concentrations. Starch source did not affect DMI, milk yield and milk components whereas feeding HS versus LS diet had higher milk yield, lactose yield and improved milk efficiency (P < 0.05). Feeding wheat- versus corn-based diet showed only greater (P < 0.05) concentration of toll-like receptor-4, whereas feeding the HS versus LS diet consistently increased blood concentrations of amyloid A, haptoglobin, LPS binding protein, and LPS (P < 0.05). Analysis of Pearson correlation coefficients illustrated that the ruminal LPS concentration is more important than faecal LPS in inflammatory responses. In conclusion, replacing corn with wheat in lactating goat diet had negative impact on ruminal pH but little effects on fermentation characteristics and milk production. Increasing the dietary concentration of starch decreased ruminal pH status and thus increased risk of acidosis, whereas, feeding HS versus LS diets resulted in an improvement in milk yield, milk efficiency, and immunity response. Moreover, rumen acidosis induced by wheat based diet was accompanied with more severe inflammatory responses.

scholarly journals Altered Intestinal Morphology and Microbiota Composition in the Autism Spectrum Disorders Associated SHANK3 Mouse Model

2019 ◽  
Vol 20 (9) ◽  
pp. 2134 ◽  
Author(s):  
Ann Katrin Sauer ◽  
Juergen Bockmann ◽  
Konrad Steinestel ◽  
Tobias M. Boeckers ◽  
Andreas M. Grabrucker
Keyword(s):  
Autism Spectrum Disorders ◽  
Inflammatory Responses ◽  
Autism Spectrum ◽  
Repetitive Behaviors ◽  
Intestinal Morphology ◽  
Microbiota Composition ◽  
Knock Out ◽  
E Coli ◽  
The Central Nervous System ◽  
Spectrum Disorders

Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterized by deficits in social interaction and communication, and repetitive behaviors. In addition, co-morbidities such as gastro-intestinal problems have frequently been reported. Mutations and deletion of proteins of the SH3 and multiple ankyrin repeat domains (SHANK) gene-family were identified in patients with ASD, and Shank knock-out mouse models display autism-like phenotypes. SHANK3 proteins are not only expressed in the central nervous system (CNS). Here, we show expression in gastrointestinal (GI) epithelium and report a significantly different GI morphology in Shank3 knock-out (KO) mice. Further, we detected a significantly altered microbiota composition measured in feces of Shank3 KO mice that may contribute to inflammatory responses affecting brain development. In line with this, we found higher E. coli lipopolysaccharide levels in liver samples of Shank3 KO mice, and detected an increase in Interleukin-6 and activated astrocytes in Shank3 KO mice. We conclude that apart from its well-known role in the CNS, SHANK3 plays a specific role in the GI tract that may contribute to the ASD phenotype by extracerebral mechanisms.

scholarly journals Impact of yeast and lactic acid bacteria on mastitis and milk microbiota composition of dairy cows

AMB Express ◽  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jing Gao ◽  
Yu-Chen Liu ◽  
Yu Wang ◽  
Han Li ◽  
Xiang-Ming Wang ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Lactic Acid Bacteria ◽  
Dairy Cows ◽  
Microbiota Composition

scholarly journals Saikosaponin A-Induced Gut Microbiota Changes Attenuate Severe Acute Pancreatitis through the Activation of Keap1/Nrf2-ARE Antioxidant Signaling

2020 ◽  
Vol 2020 ◽  
pp. 1-19
Author(s):  
Jing Li ◽  
Jinfeng Han ◽  
Juan Lv ◽  
Shiji Wang ◽  
Lai Qu ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Acute Pancreatitis ◽  
Gut Microbiota ◽  
Severe Acute Pancreatitis ◽  
Rat Model ◽  
Inflammatory Responses ◽  
Standard Diet ◽  
Microbiota Composition ◽  
Serum Lipase ◽  
Saikosaponin A

Objective. Severe acute pancreatitis (SAP) is a serious and life-threatening disease associated with multiple organ failure and a high mortality rate and is accompanied by distinct oxidative stress and inflammatory responses. Saikosaponin A has strong antioxidant properties and can affect the composition of gut microbiota. We sought to determine the effects of Saikosaponin A interventions on SAP by investigating the changes of gut microbiota and related antioxidant signaling. Methods. A SAP model was established in Sprague-Dawley (SD) rats through the injection of sodium taurocholate into the biliopancreatic duct and confirmed by elevated levels of serum lipase and amylase. The model was fed a standard diet either with saline solution or with Saikosaponin A. Fecal microbiota transplantation (FMT) from Saikosaponin A-induced rats into the rat model was performed to test the effects of gut microbiota. The composition of gut microbiota was analyzed by using 16S rRNA gene sequencing. We measured apoptotic status, inflammatory biomarkers, and Keap1-Nrf2-ARE ((Kelch-like ECH-associated protein 1) nuclear factor erythroid 2-related factor 2-antioxidant response element) antioxidant signaling. Results. Saikosaponin A intervention attenuated SAP lesions and reduced the levels of serum amylase and lipase, oxidative stress, and inflammatory responses by reducing pathological scores and affecting the serum level of oxidative and inflammatory factors. Meanwhile, the expression of Keap1-Nrf2-ARE was increased. Saikosaponin A intervention improved microbiota composition by increasing the relative abundance of Lactobacillus and Prevotella species. FMT resulted in similar results as those caused by the Saikosaponin A intervention, suggesting Saikosaponin A may exert its function via the improvement of gut microbiota composition. Conclusions. Saikosaponin A-induced gut microbiota changes attenuate SAP progression in the rat model and may be a potential natural drug for adjuvant treatment of SAP. Further work is needed to clear up the points.

scholarly journals P06.10 Lactic acid dampens inflammatory responses elicited by microbial tlr agonists from vaginal and cervical epithelial cells

2015 ◽  
Vol 91 (Suppl 2) ◽  
pp. A118.1-A118
Author(s):  
G Tachedjian ◽  
AC Hearps ◽  
D Srbinovski ◽  
D Tyssen ◽  
M Aldunate ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Epithelial Cells ◽  
Inflammatory Responses ◽  
Tlr Agonists ◽  
Cervical Epithelial Cells

scholarly journals Evaluation of the Immunomodulatory Ability of Lactic Acid Bacteria Isolated from Feedlot Cattle Against Mastitis Using a Bovine Mammary Epithelial Cells In Vitro Assay

Pathogens ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 410 ◽  
Author(s):  
Kohtaro Fukuyama ◽  
Md. Aminul Islam ◽  
Michihiro Takagi ◽  
Wakako Ikeda-Ohtsubo ◽  
Shoichiro Kurata ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Lactic Acid Bacteria ◽  
Inflammatory Responses ◽  
Interleukin 1 ◽  
Bovine Mastitis ◽  
Mammary Epithelial ◽  
Vitro Assay ◽  
Lps Challenge ◽  
Strain Dependent

Bovine mastitis, the inflammation of the mammary gland, affects the quality and quantity of milk yield. Mastitis control relies on single or multiple combinations of antibiotic therapy. Due to increasing antibiotic resistance in pathogens, the intramammary infusion of lactic acid bacteria (LAB) has been considered as a potential alternative to antibiotics for treating and preventing bovine mastitis through the improvement of the host immunity. Probiotic effects are a strain-dependent characteristic; therefore, candidate LAB strains have to be evaluated efficiently to find out the ones with the best potential. Here, we investigated LAB strains originally isolated from feedlot cattle’s environment regarding their ability in inducing the Toll-like receptor (TLR)-triggered inflammatory responses in bovine mammary epithelial (BME) cells in vitro. The BME cells were pre-stimulated with the LAB strains individually for 12, 24, and 48 h and then challenged with Escherichia coli-derived lipopolysaccharide (LPS) for 12 h. The mRNA expression of selected immune genes—interleukin 1 alpha (IL-1α), IL-1β, monocyte chemotactic protein 1 (MCP-1), IL-8, chemokine (C-X-C motif) ligand 2 (CXCL2), and CXCL3 were quantified by real-time quantitative PCR (RT-qPCR). Results indicated that pretreatment with some Lactobacillus strains were able to differentially regulate the LPS inflammatory response in BME cells; however, strain-dependent differences were found. The most remarkable effects were found for Lactobacillus acidophilus CRL2074, which reduced the expression of IL-1α, IL-1β, MCP-1, IL-8, and CXCL3, whereas Lactobacillus rhamnosus CRL2084 diminished IL-1β, MCP-1, and IL-8 expression. The pre-stimulation of BME cells with the CRL2074 strain resulted in the upregulated expression of three negative regulators of the TLRs, including the ubiquitin-editing enzyme A20 (also called tumor necrosis factor alpha-induced protein 3, TNFAIP3), single immunoglobin IL-1 single receptor (SIGIRR), and Toll interacting protein (Tollip) after the LPS challenge. The CRL2084 pre-stimulation upregulated only Tollip expression. Our results demonstrated that the L. acidophilus CRL2074 strain possess remarkable immunomodulatory abilities against LPS-induced inflammation in BME cells. This Lactobacillus strain could be used as candidate for in vivo testing due to its beneficial effects in bovine mastitis through intramammary infusion. Our findings also suggest that the BME cells immunoassay system could be of value for the in vitro evaluation of the immunomodulatory abilities of LAB against the inflammation resulting from the intramammary infection with mastitis-related pathogens.

scholarly journals Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review

PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0246953 ◽  
Author(s):  
Erica L. Plummer ◽  
Catriona S. Bradshaw ◽  
Michelle Doyle ◽  
Christopher K. Fairley ◽  
Gerald L. Murray ◽  
...  
Keyword(s):  
Systematic Review ◽  
Lactic Acid ◽  
Bacterial Vaginosis ◽  
Vaginal Microbiota ◽  
Diagnostic Methods ◽  
Control Group ◽  
Microbiota Composition ◽  
Randomised Trials ◽  
High Quality Evidence ◽  
Study Results

Objective The vaginal microbiota in bacterial vaginosis (BV) typically has low abundance of lactic acid producing lactobacilli. Lactic acid has properties that may make it effective for treating BV and/or restoring an optimal lactobacillus-dominated vaginal microbiota. We conducted a systematic review to describe the effect of intravaginal lactic acid-containing products on BV cure, and their impact on vaginal microbiota composition (PROSPERO registration: CRD42018115982). Methods PubMed, Embase and OVID were searched from inception to November 2019 to identify eligible studies. Included studies evaluated an intravaginal lactic acid-containing product and reported BV cure using established diagnostic methods, and/or vaginal microbiota composition using molecular methods. Studies were independently screened and assessed, and the proportion of women cured post-treatment was calculated. Study results were described in a qualitative manner. Results We identified 1,883 articles and assessed 57 full-texts for eligibility. Seven different lactic acid-containing products were evaluated and differed with respect to excipients, lactic acid concentration and pH. Most studies had medium or high risk of bias. Three trials compared the efficacy of a lactic acid-containing product to metronidazole for BV cure. One study found lactic acid to be equivalent to metronidazole and two studies found lactic acid to be significantly inferior to metronidazole. Two studies included a control group receiving a placebo or no treatment. One reported lactic acid to be superior than no treatment and the other reported lactic acid to be equivalent to placebo. Lactic acid-containing products did not significantly impact the vaginal microbiota composition. Conclusion There is a lack of high-quality evidence to support the use of lactic acid-containing products for BV cure or vaginal microbiota modulation. However, adequately powered and rigorous randomised trials with accompanying vaginal microbiota data are needed to evaluate the efficacy of lactic acid as a BV treatment strategy.

scholarly journals Poly(L-Lactic Acid) Composite with Surface-Modified Magnesium Hydroxide Nanoparticles by Biodegradable Oligomer for Augmented Mechanical and Biological Properties

Materials ◽  
2021 ◽  
Vol 14 (19) ◽  
pp. 5869
Author(s):  
Seung-Woon Baek ◽  
Duck Hyun Song ◽  
Ho In Lee ◽  
Da-Seul Kim ◽  
Yun Heo ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Magnesium Hydroxide ◽  
Inflammatory Responses ◽  
Biological Properties ◽  
Control Group ◽  
Biomedical Materials ◽  
Vascular Scaffolds ◽  
Surface Modified ◽  
Ph Neutralization

Poly(L-lactic acid) (PLLA) has attracted a great deal of attention for its use in biomedical materials such as biodegradable vascular scaffolds due to its high biocompatibility. However, its inherent brittleness and inflammatory responses by acidic by-products of PLLA limit its application in biomedical materials. Magnesium hydroxide (MH) has drawn attention as a potential additive since it has a neutralizing effect. Despite the advantages of MH, the MH can be easily agglomerated, resulting in poor dispersion in the polymer matrix. To overcome this problem, oligo-L-lactide-ε-caprolactone (OLCL) as a flexible character was grafted onto the surface of MH nanoparticles due to its acid-neutralizing effect and was added to the PLLA to obtain PLLA/MH composites. The pH neutralization effect of MH was maintained after surface modification. In an in vitro cell experiment, the PLLA/MH composites including OLCL-grafted MH exhibited lower platelet adhesion, cytotoxicity, and inflammatory responses better than those of the control group. Taken together, these results prove that PLLA/MH composites including OLCL-grafted MH show excellent augmented mechanical and biological properties. This technology can be applied to biomedical materials for vascular devices such as biodegradable vascular scaffolds.

Sign in / Sign up

Export Citation Format

Share Document